Back

Challenges of γ9δ2TCR affinity maturation when using phage display

Kramer, L.; Demuysere, M.; van Diest, E.; Beringer, D.; Kuball, J.

2021-05-21 immunology
10.1101/2021.05.20.445024 bioRxiv
Show abstract

BackgroundOver the past years we showed that the efficacy of {beta}T cells engineered to express a defined {gamma}{delta}TCR (TEG) depends on the functional avidity of the {gamma}9{delta}2TCR. We hypothesized that functional avidity mediated through {gamma}9{delta}2TCR in the TEG format could be further enhanced by increasing affinity of the {gamma}9{delta}2TCR. MethodsWe attempted to overcome limited affinity of natural occurring {gamma}9{delta}2TCRs through affinity maturation by phage display using a library containing mutations in CDR1 and CDR2 of both TCR chains. ConclusionAffinity maturation of {gamma}9{delta}2TCR by using phage display was not successful. The largest hurdle was the periplasmic expression of {gamma}9{delta}2TCR constructs in E.coli which is a prerequisite for successful phage display. The underlying reason for this lack of expression was the instability of the single chain (sc)TCR format. Expression of scTCR formats in HEK293F cells yielded only 15-20% correctly folded scTCR.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Journal of Immunological Methods
24 papers in training set
Top 0.1%
13.1%
2
Frontiers in Immunology
586 papers in training set
Top 0.3%
13.1%
3
PLOS ONE
4510 papers in training set
Top 21%
8.7%
4
mAbs
28 papers in training set
Top 0.1%
4.5%
5
Molecular Immunology
14 papers in training set
Top 0.1%
4.1%
6
Vaccines
196 papers in training set
Top 0.6%
3.7%
7
Antibody Therapeutics
16 papers in training set
Top 0.1%
3.7%
50% of probability mass above
8
Vaccine
189 papers in training set
Top 0.8%
3.2%
9
Human Vaccines & Immunotherapeutics
25 papers in training set
Top 0.2%
3.2%
10
F1000Research
79 papers in training set
Top 0.7%
2.8%
11
Scientific Reports
3102 papers in training set
Top 49%
2.1%
12
Immunology
29 papers in training set
Top 0.4%
1.7%
13
iScience
1063 papers in training set
Top 17%
1.5%
14
Bioinformatics
1061 papers in training set
Top 8%
1.4%
15
Cells
232 papers in training set
Top 3%
1.4%
16
Frontiers in Pharmacology
100 papers in training set
Top 3%
1.1%
17
Molecular Pharmaceutics
16 papers in training set
Top 0.4%
0.9%
18
Structure
175 papers in training set
Top 3%
0.9%
19
Viruses
318 papers in training set
Top 4%
0.9%
20
Cytotherapy
14 papers in training set
Top 0.3%
0.9%
21
Cellular and Molecular Bioengineering
21 papers in training set
Top 0.2%
0.8%
22
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.4%
0.8%
23
ImmunoHorizons
21 papers in training set
Top 0.2%
0.8%
24
ImmunoInformatics
11 papers in training set
Top 0.2%
0.7%
25
Computational and Structural Biotechnology Journal
216 papers in training set
Top 10%
0.7%
26
Open Forum Infectious Diseases
134 papers in training set
Top 3%
0.5%
27
Protein Engineering, Design and Selection
14 papers in training set
Top 0.1%
0.5%
28
Journal of Virology
456 papers in training set
Top 4%
0.5%
29
BMC Bioinformatics
383 papers in training set
Top 8%
0.5%